SANA Sana Biotechnology, Inc.
$3.13▲ +1.29%
Healthcare
Other
After hours
$3.16▲ +0.96%
Sep 11, 7:56 PM ET
Volume 3.28M
Avg Volume (10D) 3.21M
Key Metrics & Fundamentals
Market Cap
$937.00M
P/E Ratio
–
Div Yield
–%
52W Range
2.61 - 6.55
% vs 50 MA
-12.86%
% vs 200 MA
-15.33%
RSI-14
36.2
MACD Histogram
-0.1200
Beta (1Y vs SPY)
2.39
Free Cash Flow
-$34.41M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$63.19M
COGS
–
Operating Exp
$65.42M
Operating Income
-$65.42M
EBIT
-$65.42M
Pretax Income
-$63.64M
Net Income
-$63.64M
EPS (Diluted)
-0.22
Price & Volume History
Loading chart…
Recent News
Sana Biotechnology to Present at September 2026 Investor Conferences
GlobeNewswire · Sep 1, 2026 8:05 PM
Paratus Sciences Announces Updates to its Board of Directors
GlobeNewswire · Aug 26, 2026 12:00 PM
Sana Biotechnology Q2 Adjusted Loss Narrows
MT Newswires · Aug 10, 2026 8:15 PM
Sana: Q2 Earnings Snapshot
Associated Press · Aug 10, 2026 8:12 PM
Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire · Aug 10, 2026 8:05 PM
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
Zacks · Jul 20, 2026 2:49 PM
Sana Biotechnology (SANA) Publishes 14 Month Diabetes Cell Therapy Results In NEJM
Simply Wall St. · Jul 16, 2026 9:11 PM
Sana (SANA) Upgraded to Buy: Here's What You Should Know
Zacks · Jul 15, 2026 4:00 PM
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
GlobeNewswire · Jul 13, 2026 12:00 PM
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
GlobeNewswire · Jul 1, 2026 1:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SANA's money flow as a full page
Social Sentiment
Avg +0.84 · 28 posts
NewsDiscussionTradeSANA reports 1 year survival of transplanted insulin producing islets without immunosuppression
r/wallstreetbets · Jan 15, 2026
Comments express excitement and anticipation, alongside acknowledging volatility. The core discussion is centered around SANA's development.
positive
+0.60
NewsDDDiscussionSANA reports 1 year survival of transplanted insulin producing islets without immunosuppression
r/wallstreetbets · Jan 14, 2026
The post expresses strong optimism about Sana's progress towards a potential cure for Type 1 Diabetes, referring to it as a 'historic milestone' and predicting they will be first to market. High positive sentiment.
very_positive
+0.90
NewsDiscussionEarnings$SANA reports 1 year survival of transplanted insulin producing islets without immunosuppression
r/wallstreetbets · Jan 14, 2026
The announcement of 1-year islet survival without immunosuppression is a major milestone with implications for a potential diabetes cure, indicating strong positive sentiment.
very_positive
+0.90
NewsEarningsDiscussion$SANA reports 1 year survival of transplanted insulin producing islets without immunosuppression
r/wallstreetbets · Jan 14, 2026
The announcement of 1-year islet survival without immunosuppression is framed positively, suggesting a potential cure and market leadership.
very_positive
+1.00
DDPriceTarget$SANA Clause rally coming - DD inside
r/wallstreetbets · Oct 30, 2025
The post expresses strong bullish sentiment regarding $SANA, using terms like 'rally', 'Jolly Fat Man' formation, and a specific price target.
very_positive
+0.80
Page 1 of 6 (28 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.